PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 TrialConstructive Type C Meeting Provides Potential Pathway to Accelerated ...

West Pharmaceutical Services just saw its fair value estimate nudged slightly, with the price target essentially steady at ...

PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 Trial Constructive Type C Meeting Provides Potential Pathway to Accelerated Approval of PDS0101 PRINCETON, N.J., Jan. 09, 2026 (GLOBE NEW ...

Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – ...

Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Get all latest & breaking news on Board Meeting. Watch videos, top stories and articles on Board Meeting at moneycontrol.com.

Thesis Gold Inc. ("Thesis" or the "Company") (TSXV: TAU) (WKN: A3EP87) (OTCQX: THSGF) is pleased to announce the filing on ...

If you're not happy with the default Windows file manager, you're in luck because there are plenty of options that improve on the original.

The DOJ filing confirms reporting from NBC News last week that millions of files were being reviewed before their planned ...

Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus ...